粥样硬化性肾动脉狭窄行介入治疗的时机选择  

When should we do interventional therapy for atherosclerotic renal artery stenosis

作　　者：艾虎[1] 唐国栋[1] 孙福成[1] Ai Hu;Tang Guodong;Sun Fucheng(Department of Cardiology,Beijing Hospital,National Center of Gerontology,Institute of Geriatrics Medicine,Chinese Academy of Medical Sciences,Beijing 100730,China)

机构地区：[1]北京医院心内科,国家老年医学中心,中国医学科学院老年医学研究院,北京100730

出　　处：《中国临床保健杂志》2020年第6期848-850,共3页Chinese Journal of Clinical Healthcare

摘　　要：虽然介入治疗可以解除肾动脉狭窄,但粥样硬化性性肾动脉狭窄介入治疗的最佳时机尚不明确。该文从肾动脉狭窄介入治疗现状、专家共识和治疗策略转变三个方面进行综述,认为合并一过性肺水肿、全肾缺血、难治性高血压及肾功能快速减退的高危肾动脉狭窄患者可以从介入治疗中获益。Although revascularization can relieve renal artery obstruction anatomically,the best time of revascularization is not clear for atherosclerotic renal artery stenosis(ARAS).In this review,we evaluate the existing evidence and offer an approach to the management about ARAS.From the data achieved those with a hemodynamically significant ARAS in the context of Flash pulmonary edema,whole renal ischemia,refractory hypertension and/or deteriorating renal insufficiency rapidly,interventional therapy seems to be clinical benefit from revascularization.

关 键 词：肾动脉梗阻 动脉粥样硬化 血管内操作 综述 

分 类 号：R54[医药卫生—心血管疾病]